Marathon Trading Investment Management Boosted Holding in General Mtrs Co (GM) as Stock Value Declined; As Celgene (CELG) Share Price Declined, Cannell Peter B & Company Lifted Its Holding

May 25, 2018 - By Ellis Scott

General Motors Company (NYSE:GM) Logo

Bruce J. Richards increased its stake in General Mtrs Co (GM) by 172.33% based on its latest 2017Q4 regulatory filing with the SEC. Marathon Trading Investment Management Llc bought 66,400 shares as the company’s stock declined 17.02% with the market. The hedge fund run by Bruce J. Richards held 104,930 shares of the auto manufacturing company at the end of 2017Q4, valued at $4.30 million, up from 38,530 at the end of the previous reported quarter. Marathon Trading Investment Management Llc who had been investing in General Mtrs Co for a number of months, seems to be bullish on the $54.11B market cap company. The stock increased 1.43% or $0.54 during the last trading session, reaching $38.39. About 8.47M shares traded. General Motors Company (NYSE:GM) has risen 0.46% since May 25, 2017 and is uptrending. It has underperformed by 11.09% the S&P500.

J. Carlo Cannell increased its stake in Celgene Corp (CELG) by 4.42% based on its latest 2017Q4 regulatory filing with the SEC. Cannell Peter B & Company Inc bought 66,820 shares as the company’s stock declined 19.30% with the market. The hedge fund run by J. Carlo Cannell held 1.58 million shares of the major pharmaceuticals company at the end of 2017Q4, valued at $164.82 million, up from 1.51M at the end of the previous reported quarter. Cannell Peter B & Company Inc who had been investing in Celgene Corp for a number of months, seems to be bullish on the $57.77 billion market cap company. The stock increased 2.42% or $1.88 during the last trading session, reaching $79.54. About 7.88M shares traded or 5.03% up from the average. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since May 25, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Among 35 analysts covering Celgene Corporation (NASDAQ:CELG), 20 have Buy rating, 1 Sell and 14 Hold. Therefore 57% are positive. Celgene Corporation had 148 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Celgene Corporation (NASDAQ:CELG) earned “Buy” rating by Jefferies on Wednesday, October 5. On Friday, July 24 the stock rating was maintained by Cantor Fitzgerald with “Buy”. On Friday, November 17 the stock rating was maintained by BMO Capital Markets with “Outperform”. Credit Suisse maintained it with “Outperform” rating and $140 target in Tuesday, April 19 report. On Tuesday, February 13 the stock rating was upgraded by Barclays Capital to “Buy”. The firm earned “Buy” rating on Thursday, October 5 by BMO Capital Markets. Leerink Swann maintained Celgene Corporation (NASDAQ:CELG) on Monday, May 7 with “Buy” rating. The rating was initiated by Stifel Nicolaus on Friday, July 15 with “Buy”. On Friday, July 28 the stock rating was maintained by Stifel Nicolaus with “Buy”. On Thursday, October 5 the stock rating was downgraded by Morgan Stanley to “Underweight”.

Cannell Peter B & Company Inc, which manages about $3.77 billion and $2.91B US Long portfolio, decreased its stake in Meridian Bancorp Inc (NASDAQ:EBSB) by 134,870 shares to 259,095 shares, valued at $5.34 million in 2017Q4, according to the filing. It also reduced its holding in Allergan Plc by 23,835 shares in the quarter, leaving it with 1,668 shares, and cut its stake in Brookfield Infrastructure Partners (NYSE:BIP).

More notable recent Celgene Corporation (NASDAQ:CELG) news were published by: Seekingalpha.com which released: “Is Celgene’s Stock A Buy The Dip Opportunity?” on May 23, 2018, also Benzinga.com with their article: “Celgene Forges Oncology Partnership With Germany’s Evotec” published on May 22, 2018, Seekingalpha.com published: “Will ‘Public Shaming’ Sink Celgene?” on May 21, 2018. More interesting news about Celgene Corporation (NASDAQ:CELG) were released by: Finance.Yahoo.com and their article: “Celgene Corporation: How to Effectively Buy Into CELG Stock” published on May 22, 2018 as well as Seekingalpha.com‘s news article titled: “Generic Revlimid Could Sink Celgene” with publication date: May 16, 2018.

Since February 8, 2018, it had 2 insider purchases, and 3 selling transactions for $3.48 million activity. $299,594 worth of stock was bought by Alles Mark J on Thursday, February 8. Shares for $1.26 million were sold by MARIO ERNEST. Another trade for 18,500 shares valued at $1.77M was sold by KAPLAN GILLA.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.34, from 1.17 in 2017Q3. It turned negative, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Oakbrook Invs Limited Liability has 0.28% invested in Celgene Corporation (NASDAQ:CELG). Assetmark invested in 0.01% or 10,625 shares. Fil reported 645,711 shares. Kentucky Retirement Insur Trust Fund reported 20,909 shares. Mitchell Cap Mngmt holds 19,579 shares. Da Davidson & Company has 50,393 shares for 0.11% of their portfolio. Richard Bernstein Advsr Ltd Company reported 22,125 shares. Moreover, Factory Mutual Ins has 0.76% invested in Celgene Corporation (NASDAQ:CELG) for 695,700 shares. Scotia Cap Inc invested 0.1% in Celgene Corporation (NASDAQ:CELG). Natixis Asset Mgmt, a France-based fund reported 1,914 shares. Badgley Phelps Bell invested in 0.66% or 91,475 shares. New York-based Tocqueville Asset Management Lp has invested 0.13% in Celgene Corporation (NASDAQ:CELG). Burns J W & Inc New York owns 47,748 shares for 1.26% of their portfolio. 8.24M are held by Goldman Sachs Gp. Birch Hill Advsrs Ltd Co, Massachusetts-based fund reported 316,776 shares.

Among 29 analysts covering General Motors Company (NYSE:GM), 17 have Buy rating, 3 Sell and 9 Hold. Therefore 59% are positive. General Motors Company had 94 analyst reports since July 24, 2015 according to SRatingsIntel. Standpoint Research downgraded General Motors Company (NYSE:GM) on Thursday, September 14 to “Hold” rating. On Tuesday, August 9 the stock rating was initiated by Jefferies with “Hold”. On Tuesday, December 19 the stock rating was upgraded by RBC Capital Markets to “Outperform”. The firm has “Hold” rating given on Monday, October 30 by Jefferies. CLSA initiated the shares of GM in report on Wednesday, June 21 with “Hold” rating. The stock of General Motors Company (NYSE:GM) earned “Overweight” rating by Morgan Stanley on Monday, April 9. The rating was upgraded by Credit Suisse to “Outperform” on Monday, January 11. Piper Jaffray maintained it with “Buy” rating and $4400 target in Tuesday, July 11 report. Craig Hallum maintained General Motors Company (NYSE:GM) rating on Wednesday, October 25. Craig Hallum has “Hold” rating and $45.0 target. Jefferies maintained General Motors Company (NYSE:GM) rating on Monday, June 12. Jefferies has “Hold” rating and $3600 target.

More notable recent General Motors Company (NYSE:GM) news were published by: Seekingalpha.com which released: “HyreCar files for IPO” on May 24, 2018, also Globenewswire.com with their article: “General Motors (GM) Recognizes Lydall for Performance, Quality, and Innovation” published on May 07, 2018, Livetradingnews.com published: “General Motors Company (NYSE:GM) Heffx Technical Analysis” on May 23, 2018. More interesting news about General Motors Company (NYSE:GM) were released by: Businesswire.com and their article: “Ryder Named GM Supplier of the Year by General Motors” published on May 23, 2018 as well as Seekingalpha.com‘s news article titled: “GM goes dark on monthly auto sales” with publication date: May 01, 2018.

Marathon Trading Investment Management Llc, which manages about $886.83M and $3.59B US Long portfolio, decreased its stake in Spdr Series Trust (Put) by 26,500 shares to 738,900 shares, valued at $27.47M in 2017Q4, according to the filing. It also reduced its holding in Snap Inc (Call) by 37,500 shares in the quarter, leaving it with 105,400 shares, and cut its stake in Citigroup Inc (Call).

General Motors Company (NYSE:GM) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>